Tuesday, 04 Nov 2025

AlzeCure presents phase 2 data on ACD440 at NeuPSIG 2025

Written by
PharmaTimes
Published
Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago